Drugs / Influvac
Trials 12
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial · 1 missed | ||||||
| Phase 2/3 | NCT00371098 | Oct 2004 → Dec 2005 | coronary artery disorder | National Institute of Cardiology, Warsaw, Poland | Completed | Missed primary |
| Phase 39 trials | ||||||
| Phase 3 | NCT02381418 | Mar 2015 | influenza | Abbott | Completed | No outcome recorded |
| Phase 3 | NCT01633749 | Jul 2012 | — | Abbott Biologicals | Completed | No outcome recorded |
| Phase 3 | NCT01146015 | Jun → Jul 2010 | influenza | Abbott Biologicals | Completed | No outcome recorded |
| Phase 3 | NCT00999206 | Jan → Aug 2010 | influenza | Abbott Biologicals | Completed | No outcome recorded |
| Phase 3 | NCT00881842 | Jun → Jul 2009 | influenza | Abbott Biologicals | Completed | No outcome recorded |
| Phase 3 | NCT00665509 | Jun → Jul 2008 | influenza | Solvay Biologicals | Completed | No outcome recorded |
| Phase 3 | NCT00479921 | Jun 2007 → ? | — | Solvay Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00346723 | Jul 2006 → ? | — | Solvay Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00325260 | Mar 2006 → ? | — | Solvay Pharmaceuticals | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05070494 | Mar 2021 → Apr 2022 | end stage renal failure | Mahidol University | Unknown | No outcome recorded |
| Phase 4 | NCT01119157 | Nov 2008 → Mar 2009 | — | National Centre for Epidemiology, Hungary | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT04122222 Comparator | Aug 2016 → Jul 2018 | — | Mahidol University | Completed | No outcome recorded |
| — | NCT00679237 Comparator | Sep 2007 → Dec 2019 | coronary artery disorder | Sorlandet Hospital HF | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influvac | “The current study is a phase IIIa clinical trial with a commercially available vaccine (Influvac®) supplied in pre filled syringes.” NCT00479921 ↗14“A single standard dose of inactivated trivalent influenza vaccine: Influvac® vaccines (Abbott, the Netherlands), intramuscularly.” NCT04122222 ↗ “The details of using Influvac vaccine of that year are produced by Abbott.” NCT05070494 ↗ “surface antigen, inactivated, prepared in egg (influvac ®)” NCT00999206 ↗ “commercially available vaccine (Influvac®)” NCT02381418 ↗ “vaccine (FLuarix, Influvac etc)” NCT00679237 ↗ “Influvac” NCT01119157 ↗ |
| Modality | Vaccine | “subunit influenza vaccine” NCT00325260 ↗ |
| Route | Intramuscular | “Influvac® subunit influenza vaccine for i.m./deep s.c.injection” NCT00346723 ↗ |
| Route | Subcutaneous | “Influvac® subunit influenza vaccine for i.m./deep s.c.injection” NCT00346723 ↗ |